Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone
- PMID: 849672
- DOI: 10.1002/cpt1977214409
Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone
Abstract
We examined naloxone-precipitated withdrawal as a means for rapid opiate detoxification and induction onto naltrexone. In 29 patients dependent on methadone (5 to 20 mg/day), abstinence was precipitated by an injection of naloxone. Repeated injections of naloxone were given subsequently until symptoms of abstinence were no longer induced. Successive injections induced less intense withdrawal assessed by vital signs and ratings on abstinence scales. The most rapid procedure consisted of 1.2 mg naxolone every 30 min for 3 to 6 hr, for 3 to 6 hr, followed by hourly increasing doses of naltrexone. This procedure allowed transition from opiate dependence to naltrexone maintenance (50 to 100 mg/day) within 48 hr. The results are consistent with assumptions that antagonists actively displace opiates from receptor sites.
Similar articles
-
Naltrexone in the treatment of opiate dependence.NIDA Res Monogr. 1978;(19):321-32. NIDA Res Monogr. 1978. PMID: 218108 No abstract available.
-
Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.Am J Psychiatry. 1991 Jul;148(7):933-5. doi: 10.1176/ajp.148.7.933. Am J Psychiatry. 1991. PMID: 2053636
-
[The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].Zhonghua Yi Xue Za Zhi. 1999 Sep;79(9):679-82. Zhonghua Yi Xue Za Zhi. 1999. PMID: 11715458 Chinese.
-
Methadone maintenance and narcotic blocking drugs. Appendix.Int J Addict. 1977 Oct;12(7):869-81. doi: 10.3109/10826087709027257. Int J Addict. 1977. PMID: 338517 Review.
-
Opiate detoxification protocols. A clinical manual.Ann Clin Psychiatry. 1993 Mar;5(1):53-65. doi: 10.3109/10401239309148924. Ann Clin Psychiatry. 1993. PMID: 8394176 Review.
Cited by
-
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.Am J Addict. 2018 Apr;27(3):177-187. doi: 10.1111/ajad.12711. Am J Addict. 2018. PMID: 29596725 Free PMC article. Review.
-
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity.J Med Chem. 2023 Jan 12;66(1):577-595. doi: 10.1021/acs.jmedchem.2c01499. Epub 2022 Dec 20. J Med Chem. 2023. PMID: 36538027 Free PMC article.
-
Opioid peptides and primary biliary cirrhosis.BMJ. 1988 Dec 10;297(6662):1501-4. doi: 10.1136/bmj.297.6662.1501. BMJ. 1988. PMID: 3147046 Free PMC article. Clinical Trial.
-
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.ACS Chem Neurosci. 2019 May 15;10(5):2518-2532. doi: 10.1021/acschemneuro.9b00038. Epub 2019 Feb 21. ACS Chem Neurosci. 2019. PMID: 30758946 Free PMC article.
-
Single and repeated ultra-rapid detoxification prevents cognitive impairment in morphine addicted rats: a privilege for single detoxification.Addict Health. 2014 Winter;6(1-2):54-64. Addict Health. 2014. PMID: 25140218 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources